These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19740612)

  • 1. Randomized response estimates for doping and illicit drug use in elite athletes.
    Striegel H; Ulrich R; Simon P
    Drug Alcohol Depend; 2010 Jan; 106(2-3):230-2. PubMed ID: 19740612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doping, drugs and drug abuse among adolescents in the State of Thuringia (Germany): prevalence, knowledge and attitudes.
    Wanjek B; Rosendahl J; Strauss B; Gabriel HH
    Int J Sports Med; 2007 Apr; 28(4):346-53. PubMed ID: 17024651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doping in fitness sports: estimated number of unreported cases and individual probability of doping.
    Simon P; Striegel H; Aust F; Dietz K; Ulrich R
    Addiction; 2006 Nov; 101(11):1640-4. PubMed ID: 17034444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system.
    Striegel H; Simon P; Frisch S; Roecker K; Dietz K; Dickhuth HH; Ulrich R
    Drug Alcohol Depend; 2006 Jan; 81(1):11-9. PubMed ID: 16009506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug testing in elite athletes--the Israeli perspective.
    Epstein S; Eliakim A
    Isr Med Assoc J; 1999 Oct; 1(2):79-82. PubMed ID: 10731300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of illicit drug use among the Italian athlete population with special attention on drugs of abuse: a 10-year review.
    Strano Rossi S; Botrè F
    J Sports Sci; 2011 Mar; 29(5):471-6. PubMed ID: 21279865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of doping in Flanders in comparison to the prevalence of doping in international sports.
    Van Eenoo P; Delbeke FT
    Int J Sports Med; 2003 Nov; 24(8):565-70. PubMed ID: 14598191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doping in Two Elite Athletics Competitions Assessed by Randomized-Response Surveys.
    Ulrich R; Pope HG; Cléret L; Petróczi A; Nepusz T; Schaffer J; Kanayama G; Comstock RD; Simon P
    Sports Med; 2018 Jan; 48(1):211-219. PubMed ID: 28849386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between physical and cognitive doping--a cross-sectional study in 2.997 triathletes.
    Dietz P; Ulrich R; Dalaker R; Striegel H; Franke AG; Lieb K; Simon P
    PLoS One; 2013; 8(11):e78702. PubMed ID: 24236038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the prevalence of anabolic steroids, stimulants, and selected drugs subject to doping controls among elite sport students using analytical chemistry.
    Thevis M; Sauer M; Geyer H; Sigmund G; Mareck U; Schänzer W
    J Sports Sci; 2008 Aug; 26(10):1059-65. PubMed ID: 18608840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance use and misuse among Slovenian table tennis players.
    Kondric M; Sekulic D; Mandic GF
    Subst Use Misuse; 2010 Mar; 45(4):543-53. PubMed ID: 20141464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-reported attitudes of elite athletes towards doping: differences between type of sport.
    Alaranta A; Alaranta H; Holmila J; Palmu P; Pietilä K; Helenius I
    Int J Sports Med; 2006 Oct; 27(10):842-6. PubMed ID: 16586338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anabolic steroid use among adolescents in a rural state.
    Whitehead R; Chillag S; Elliott D
    J Fam Pract; 1992 Oct; 35(4):401-5. PubMed ID: 1402727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction profiles for nutritional supplement use among young German elite athletes.
    Dietz P; Ulrich R; Niess A; Best R; Simon P; Striegel H
    Int J Sport Nutr Exerc Metab; 2014 Dec; 24(6):623-31. PubMed ID: 24901677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elite athletes' estimates of the prevalence of illicit drug use: evidence for the false consensus effect.
    Dunn M; Thomas JO; Swift W; Burns L
    Drug Alcohol Rev; 2012 Jan; 31(1):27-32. PubMed ID: 21450047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of doping use in elite sports: a review of numbers and methods.
    de Hon O; Kuipers H; van Bottenburg M
    Sports Med; 2015 Jan; 45(1):57-69. PubMed ID: 25169441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can we measure accurately the prevalence of doping?
    Lentillon-Kaestner V; Ohl F
    Scand J Med Sci Sports; 2011 Dec; 21(6):e132-42. PubMed ID: 22126721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doping prevalence among preadolescent athletes: a 4-year follow-up.
    Laure P; Binsinger C
    Br J Sports Med; 2007 Oct; 41(10):660-3; discussion 663. PubMed ID: 17473000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs, recreational drug use and attitudes towards doping of high school athletes.
    Laure P; Lecerf T; Friser A; Binsinger C
    Int J Sports Med; 2004 Feb; 25(2):133-8. PubMed ID: 14986197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of nutritional supplements among master athletes.
    Striegel H; Simon P; Wurster C; Niess AM; Ulrich R
    Int J Sports Med; 2006 Mar; 27(3):236-41. PubMed ID: 16541381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.